Institution · SKiN Health
Most cited papers from SKiN Health
What are the most cited papers from SKiN Health?
The most cited paper from SKiN Health is "Pyroptosis: mechanisms and diseases" (Pian Yu, Xu Zhang, Nian Liu et al., 2021), with 2,406 citations. Next come "Guidelines of care for the management of atopic dermatitis" (1,280) and "Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies" (864).
Showing 50 of 59 papers. Every paper with more than 104 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Pyroptosis: mechanisms and diseases Pian Yu, Xu Zhang, Nian Liu et al. · Signal Transduction and Targeted Therapy | 28 Mar 2021 | 2,406 |
| 2 | Guidelines of care for the management of atopic dermatitis Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology | 27 Nov 2013 | 1,280 |
| 3 | Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies Qian Zhou, Yu Meng, Daishi Li et al. · Signal Transduction and Targeted Therapy | 7 Mar 2024 | 864 |
| 4 | Alopecia areata update Abdullah Alkhalifah, Adel Alsantali, Eddy Wang et al. · Journal of the American Academy of Dermatology | 15 Jan 2010 | 735 |
| 5 | The mechanisms of lysophosphatidylcholine in the development of diseases Panpan Liu, Wu Zhu, Chao Chen et al. · Life Sciences | 18 Feb 2020 | 591 |
| 6 | Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis Eric Lawrence Simpson et al. · JAMA Dermatology | 6 Nov 2019 | 519 |
| 7 | Avoiding and Treating Blindness From Fillers Katie Beleznay, JEAN D. A. CARRUTHERS, Shannon D. Humphrey et al. · Dermatologic Surgery | 10 Sep 2015 | 518 |
| 8 | Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Andrew Blauvelt, Henrique D. Teixeira, Eric Lawrence Simpson et al. · JAMA Dermatology | 4 Aug 2021 | 504 |
| 9 | Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) Carle F. Paul, Jennifer Clay Cather, Melinda Gooderham et al. · British Journal of Dermatology | 11 Sep 2015 | 485 |
| 10 | Signaling pathways and targeted therapies for psoriasis Jia Guo, Hongchan Zhang, Wenrui Lin et al. · Signal Transduction and Targeted Therapy | 26 Nov 2023 | 418 |
| 11 | European S2k Guideline on Chronic Pruritus Elke Weißhaar, Jacek Cezary Szepietowski, Florence Dalgard et al. · Acta Dermato Venereologica | 2019 | 406 |
| 12 | Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial Amy S. Paller et al. · Journal of the American Academy of Dermatology | 20 Jun 2020 | 399 |
| 13 | Dupilumab: A review of its use in the treatment of atopic dermatitis Melinda Gooderham, Hwanhee Hong, Panteha Eshtiaghi et al. · Journal of the American Academy of Dermatology | 19 Feb 2018 | 343 |
| 14 | Guidelines of care for the management of atopic dermatitis Robert Sidbury et al. · Journal of the American Academy of Dermatology | 26 Sep 2014 | 327 |
| 15 | Psoriasis and Pustular Dermatitis Triggered by TNF-α Inhibitors in Patients With Rheumatologic Conditions Gillian C. de Gannes, Mehran Ghoreishi, Janet Elizabeth Pope et al. · Archives of Dermatology | Feb 2007 | 326 |
| 16 | A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial Philip J. Mease, Josef S Smolen, Frank Behrens et al. · Annals of the Rheumatic Diseases | 28 Sep 2019 | 292 |
| 17 | A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma Ortonne Jp, I. Reig Rincón de Arellano, Mark Berneburg et al. · Journal of the European Academy of Dermatology and Venereology | 25 May 2009 | 275 |
| 18 | Estrogens and aging skin Margaret Julie Thornton · Dermato-Endocrinology | Apr 2013 | 270 |
| 19 | ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis Hong Liu et al. · Cancer Cell | Mar 2020 | 264 |
| 20 | Infrared and skin: Friend or foe Daniel Barolet, François J. Christiaens, Michael R. Hamblin · Journal of Photochemistry and Photobiology B Biology | 21 Dec 2015 | 248 |
| 21 | Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis Melinda Gooderham, Seth B. Forman, Robert Bissonnette et al. · JAMA Dermatology | 2 Oct 2019 | 244 |
| 22 | The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma Howard L. Kaufman et al. · Nature Reviews Clinical Oncology | 27 Aug 2013 | 199 |
| 23 | Focal Treatment of Acne Scars With Trichloroacetic Acid: Chemical Reconstruction of Skin Scars Method Jung Bock Lee, Woo Gil Chung, Ho Kwahck et al. · Dermatologic Surgery | Nov 2002 | 193 |
| 24 | Infection and the Chronic Wound Robert A. Warriner, Robert Edward Burrell · Advances in Skin & Wound Care | Oct 2005 | 193 |
| 25 | Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction Mingzhu Yin, Ying Guo, Rui Hu et al. · Nature Communications | 14 Apr 2020 | 191 |
| 26 | Corticosteroid Adverse Effects Muhammad Yasir, Amandeep Goyal, Pankaj Bansal et al. · StatPearls | Oct 2019 | 183 |
| 27 | Clinical Relevance of Elastin in the Structure and Function of Skin Leslie Baumann, Eric F. Bernstein, Anthony S. Weiss et al. · Aesthetic Surgery Journal Open Forum | 14 May 2021 | 181 |
| 28 | Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin Ronald Lee Nichols, Donald R. Graham, Steven L. Barriere et al. · Journal of Antimicrobial Chemotherapy | Aug 1999 | 178 |
| 29 | Tumour vasculature at single-cell resolution Pan Xu, Xin Li, Liang Dong et al. · Nature | 10 Jul 2024 | 170 |
| 30 | The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer Ziyu Guo, Danyao Chen, Lei Yao et al. · Signal Transduction and Targeted Therapy | 8 May 2025 | 162 |
| 31 | Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1 Youqiong Ye et al. · Genome Medicine | 28 Sep 2020 | 159 |
| 32 | Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers Liren Tang, Derek L. Dai, Mingwan Su et al. · Clinical Cancer Research | 15 Jun 2006 | 153 |
| 33 | Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis Eric Lawrence Simpson et al. · JAMA Dermatology | 11 Jan 2023 | 151 |
| 34 | Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies Marjolein S. de Bruin-Weller, Tilo M. Biedermann, Robert Bissonnette et al. · Acta Dermato Venereologica | 2021 | 150 |
| 35 | Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials Thomas R.M. Bieber, Jacob Pontoppidan Thyssen, Kristian Reich et al. · Journal of the European Academy of Dermatology and Venereology | 18 Sep 2020 | 148 |
| 36 | Delayed-Onset Nodules Secondary to a Smooth Cohesive 20 mg/mL Hyaluronic Acid Filler Katie Beleznay, JEAN D. A. CARRUTHERS, Alastair Carruthers et al. · Dermatologic Surgery | 11 Jul 2015 | 148 |
| 37 | Differences in body mass index among individuals with PsA, psoriasis, RA and the general population Vidula Bhole, Hyon K. Choi, L.C. Burns et al. · Lara D. Veeken | 25 Nov 2011 | 148 |
| 38 | Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study Kim Alexander Papp, Hervé Bachelez, Antonio Costanzo et al. · Journal of the American Academy of Dermatology | 10 Mar 2017 | 140 |
| 39 | Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial Cancan Huang, Ping Yi, Ming Zhu et al. · Journal of Autoimmunity | Jun 2022 | 136 |
| 40 | Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo Xuesong Wu, Brian C. Schulte, Youwen Zhou et al. · Journal of Investigative Dermatology | 29 Apr 2014 | 135 |
| 41 | Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis Chih-ho Hong, Mark Lupin, Kathryn F. O′Shaughnessy · Dermatologic Surgery | 27 Mar 2012 | 129 |
| 42 | Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease Marie‐Charlotte Brüggen, Irene Klein, Hildegard Greinix et al. · Blood | 20 Nov 2013 | 127 |
| 43 | Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR) Bruce E Strober, Melinda Gooderham, Elke M. G. J. de Jong et al. · Journal of the American Academy of Dermatology | 6 Nov 2017 | 124 |
| 44 | Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne Jerry K.L. Tan, Diane M. Thiboutot, Georg Popp et al. · Journal of the American Academy of Dermatology | 22 Feb 2019 | 123 |
| 45 | A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial* Andrew Blauvelt, C. Leonardi, Boni Elizabeth Elewski et al. · British Journal of Dermatology | 2 Sep 2020 | 122 |
| 46 | The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity Anastasiya Muntyanu, Sofianne Gabrielli, Jeffrey C. H. Donovan et al. · Journal of the European Academy of Dermatology and Venereology | 28 Jan 2023 | 121 |
| 47 | PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: Results of a randomized phase IIa trial Greg Siller, Robert Rosen, Michael L. Freeman et al. · Australasian Journal of Dermatology | 12 Mar 2010 | 121 |
| 48 | Noninferiority of IncobotulinumtoxinA, Free from Complexing Proteins, Compared with Another Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines Gerhard Sattler, MICHAEL J. CALLANDER, Doris Grablowitz et al. · Dermatologic Surgery | Dec 2010 | 119 |
| 49 | Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy Ying Jing, Xue Chen, Xue Chen et al. · Journal for ImmunoTherapy of Cancer | 2022 | 118 |
| 50 | Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis Mark Lebwohl et al. · JAMA | 20 Sep 2022 | 117 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.